EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
2.8.2.5 | chondroitin 4-sulfotransferase |
spinal cord |
isozyme C4ST2 expression |
645917 |
3.1.1.116 | sn-1-specific diacylglycerol lipase |
spinal cord |
- |
761044 |
3.1.1.23 | acylglycerol lipase |
spinal cord |
neuron enriched cultures from fetal spinal cord |
94274 |
3.1.1.32 | phospholipase A1 |
spinal cord |
low expression |
694548 |
3.1.1.4 | phospholipase A2 |
spinal cord |
- |
133865, 705323 |
3.1.1.4 | phospholipase A2 |
spinal cord |
isoform cPLA2-alpha |
653367 |
3.1.1.45 | carboxymethylenebutenolidase |
spinal cord |
transcript detected by RT-PCR |
704653 |
3.1.1.5 | lysophospholipase |
spinal cord |
- |
695206 |
3.1.1.7 | acetylcholinesterase |
spinal cord |
- |
114132, 114195 |
3.1.2.2 | palmitoyl-CoA hydrolase |
spinal cord |
- |
646167 |
3.1.2.20 | acyl-CoA hydrolase |
spinal cord |
- |
646167 |
3.1.3.16 | protein-serine/threonine phosphatase |
spinal cord |
- |
664479 |
3.1.3.16 | protein-serine/threonine phosphatase |
spinal cord |
ventral cervical spinal cord |
693756 |
3.1.3.46 | fructose-2,6-bisphosphate 2-phosphatase |
spinal cord |
- |
729793 |
3.1.3.48 | protein-tyrosine-phosphatase |
spinal cord |
- |
694827, 709631 |
3.1.3.5 | 5'-nucleotidase |
spinal cord |
- |
709642 |
3.1.3.5 | 5'-nucleotidase |
spinal cord |
spinal cord astrocyte |
751384 |
3.1.3.64 | phosphatidylinositol-3-phosphatase |
spinal cord |
ventral roots of spinal cord |
682009 |
3.1.4.11 | phosphoinositide phospholipase C |
spinal cord |
- |
667504 |
3.1.4.17 | 3',5'-cyclic-nucleotide phosphodiesterase |
spinal cord |
cervical spinal cord, expression of isoforms PDE2, PDE5, and PDE9 in all lamina, in ventral motor neurons and in ependymal cells lining the central canal. Study on the influence of enzyme activity on NO-stimulated cGMP levels |
681045 |
3.1.4.35 | 3',5'-cyclic-GMP phosphodiesterase |
spinal cord |
cervical spinal cord, expression of isoforms PDE2, PDE5, and PDE9 in all lamina, in ventral motor neurons and in ependymal cells lining the central canal. Study on the influence of enzyme activity on NO-stimulated cGMP levels |
681045 |
3.1.4.37 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase |
spinal cord |
- |
135381, 710624 |
3.1.4.37 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase |
spinal cord |
of injured rat |
681551 |
3.1.4.39 | alkylglycerophosphoethanolamine phosphodiesterase |
spinal cord |
- |
705323 |
3.1.4.53 | 3',5'-cyclic-AMP phosphodiesterase |
spinal cord |
- |
678086 |
3.1.6.1 | arylsulfatase (type I) |
spinal cord |
activity increases gradually during development |
135532 |
3.1.6.12 | N-acetylgalactosamine-4-sulfatase |
spinal cord |
ARSB is extensively expressed and distributed in the entire spinal cord. Expression in anterior horn of gray matter is significantly higher than that in the posterior horn of gray matter and significantly higher than that in the central canal. ARSB is mainly distributed in the microglia and neuron cells in the wild-type mice |
751603 |
3.1.8.1 | aryldialkylphosphatase |
spinal cord |
fibre tracts of the spinal cord, PON1 |
692441 |
3.2.1.33 | amylo-alpha-1,6-glucosidase |
spinal cord |
- |
680002 |
3.3.2.6 | leukotriene-A4 hydrolase |
spinal cord |
enzyme expression analysis, LTA4h mRNA is expressed in both spinal neurons and microglia, overview |
708600 |
3.3.2.6 | leukotriene-A4 hydrolase |
spinal cord |
lamina II of the spinal cord |
683929 |
3.4.11.7 | glutamyl aminopeptidase |
spinal cord |
- |
699650 |
3.4.14.4 | dipeptidyl-peptidase III |
spinal cord |
superficial laminae of the spinal cord dorsal horn |
683203 |
3.4.17.21 | Glutamate carboxypeptidase II |
spinal cord |
- |
655503, 668486, 669923, 701206 |
3.4.17.22 | metallocarboxypeptidase D |
spinal cord |
- |
28971 |
3.4.18.1 | cathepsin X |
spinal cord |
- |
683448 |
3.4.18.1 | cathepsin X |
spinal cord |
grey and white matter |
696995 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
spinal cord |
- |
682875 |
3.4.19.12 | ubiquitinyl hydrolase 1 |
spinal cord |
specific carbonyl level of UCH-L1 is significantly increased in spinal cord of G93A-SOD1 transgenic mice compared to that of nontransgenic mice |
668696 |
3.4.19.6 | pyroglutamyl-peptidase II |
spinal cord |
cervicyl, thoracic and munbar |
647288 |
3.4.21.108 | HtrA2 peptidase |
spinal cord |
- |
710093 |
3.4.21.117 | stratum corneum chymotryptic enzyme |
spinal cord |
- |
647349 |
3.4.21.26 | prolyl oligopeptidase |
spinal cord |
- |
709257 |
3.4.21.34 | plasma kallikrein |
spinal cord |
prekallikrein expression |
653115 |
3.4.21.35 | tissue kallikrein |
spinal cord |
- |
681539 |
3.4.21.B10 | neurosin |
spinal cord |
- |
-, 731563, 732361 |
3.4.21.B10 | neurosin |
spinal cord |
Klk6 expression is elevated in the spinal cord of mice with experimental autoimmune encephalomyelitis at the peak of clinical disease |
752883 |
3.4.21.B10 | neurosin |
spinal cord |
splice variant 3 is preferentially expressed in spinal cord, mammary, and salivary glands and to lesser extent in protstate |
663841 |
3.4.21.B12 | prostase |
spinal cord |
medium expression level |
647334 |
3.4.21.B40 | kallikrein 9 |
spinal cord |
- |
647358 |
3.4.22.1 | cathepsin B |
spinal cord |
- |
668520 |
3.4.22.27 | cathepsin S |
spinal cord |
- |
682543, 697041 |
3.4.22.27 | cathepsin S |
spinal cord |
grey and white matter |
696995 |
3.4.22.52 | calpain-1 |
spinal cord |
- |
709152, 710087, 731222 |
3.4.22.56 | caspase-3 |
spinal cord |
- |
707001 |
3.4.22.60 | caspase-7 |
spinal cord |
- |
700613 |
3.4.22.64 | caspase-11 |
spinal cord |
- |
699691 |
3.4.23.45 | memapsin 1 |
spinal cord |
- |
638894, 638903 |
3.4.23.46 | memapsin 2 |
spinal cord |
- |
713110 |
3.4.23.5 | cathepsin D |
spinal cord |
- |
699885 |
3.4.24.11 | neprilysin |
spinal cord |
- |
81618, 81643 |
3.4.24.11 | neprilysin |
spinal cord |
pial membranes associated with brain and spinal cord |
81608 |
3.4.24.15 | thimet oligopeptidase |
spinal cord |
- |
37064 |
3.4.24.22 | stromelysin 2 |
spinal cord |
- |
707310 |
3.4.24.82 | ADAMTS-4 endopeptidase |
spinal cord |
- |
669068 |
3.4.24.B10 | ADAM12 endopeptidase |
spinal cord |
- |
719334 |
3.4.24.B5 | matrix metalloproteinase-15 |
spinal cord |
MMP-15 message is down-regulated 5.5fold in experimental autoimmune encephalomyelitis |
669713 |
3.5.1.15 | aspartoacylase |
spinal cord |
- |
209002 |
3.5.1.2 | glutaminase |
spinal cord |
low expression level of isozymes LGA and KGA |
670391 |
3.5.1.4 | amidase |
spinal cord |
- |
690174 |
3.5.1.99 | fatty acid amide hydrolase |
spinal cord |
- |
712828 |
3.5.3.15 | protein-arginine deiminase |
spinal cord |
- |
684402, 712824, 733680 |
3.5.3.18 | dimethylargininase |
spinal cord |
DDAH-1 mRNA expression is especially strong in the ventral horn and dorsal root ganglion, and also localized in cervical, thoracic and lumbar spinal cord and sympathetic ganglion |
668120 |
3.5.3.18 | dimethylargininase |
spinal cord |
in the gray matter, especially in the ventral portion and sympathetic ganglion |
668120 |
3.5.4.4 | adenosine deaminase |
spinal cord |
- |
209610 |
3.6.1.13 | ADP-ribose diphosphatase |
spinal cord |
- |
209946, 655991 |
4.1.1.28 | aromatic-L-amino-acid decarboxylase |
spinal cord |
- |
747840 |
4.1.2.27 | sphinganine-1-phosphate aldolase |
spinal cord |
- |
5119 |
4.1.2.27 | sphinganine-1-phosphate aldolase |
spinal cord |
high expression rate |
728089 |
4.2.2.20 | chondroitin-sulfate-ABC endolyase |
spinal cord |
- |
681541 |
4.2.99.18 | DNA-(apurinic or apyrimidinic site) lyase |
spinal cord |
reduction in APE1 expression after ischemia |
690474 |
4.4.1.20 | leukotriene-C4 synthase |
spinal cord |
throughout the gray matter |
708600 |
4.6.1.1 | adenylate cyclase |
spinal cord |
lumbar spinal cord segments |
694374 |
4.6.1.2 | guanylate cyclase |
spinal cord |
- |
681089 |
4.6.1.2 | guanylate cyclase |
spinal cord |
NO-GC is distinctly expressed in neurons of the mouse dorsal horn |
693769 |
4.6.1.2 | guanylate cyclase |
spinal cord |
present at weaker levels |
681091 |
5.1.3.19 | chondroitin-glucuronate 5-epimerase |
spinal cord |
fetal |
749120 |
5.3.4.1 | protein disulfide-isomerase |
spinal cord |
- |
705291 |
5.3.4.1 | protein disulfide-isomerase |
spinal cord |
lumbar, segments |
702970 |
5.3.99.2 | Prostaglandin-D synthase |
spinal cord |
glutathione-independent enzyme |
3121 |
5.6.1.1 | microtubule-severing ATPase |
spinal cord |
- |
699690 |
6.1.1.1 | tyrosine-tRNA ligase |
spinal cord |
- |
676126 |
6.1.1.12 | aspartate-tRNA ligase |
spinal cord |
- |
676127, 693741 |
6.1.1.23 | aspartate-tRNAAsn ligase |
spinal cord |
- |
693741 |
6.2.1.16 | acetoacetate-CoA ligase |
spinal cord |
low expression level |
691065 |
6.3.1.2 | glutamine synthetase |
spinal cord |
and hemicord |
695162 |
6.3.1.2 | glutamine synthetase |
spinal cord |
neural enzyme is retained in the cytoplasm. Two different glutamine synthetase transcripts are generated by tissue-specific alternative splicing. The liver transcript contains an alternative exon that is not present in the neural one |
661765 |
6.3.1.2 | glutamine synthetase |
spinal cord |
no significant changes in the enzyme activity between morphine-treated and control samples |
713737 |
6.3.2.11 | carnosine synthase |
spinal cord |
- |
993 |
6.3.2.24 | tyrosine-arginine ligase |
spinal cord |
- |
648948 |